4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline
C22H29ClN2O — CID 158541469
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline
4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline (PubChem CID 158541469) has the molecular formula C22H29ClN2O and a molecular weight of 372.94 g/mol. Its IUPAC name is 4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline.
Molecular Properties
| Compound Name | 4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline |
|---|---|
| PubChem CID | 158541469 |
| Molecular Formula | C22H29ClN2O |
| Molecular Weight | 372.94 g/mol |
| Exact Mass | 372.20 |
| IUPAC Name | 4-(4-chlorophenyl)-1-methylpiperidin-4-ol;2-methyl-3,4-dihydro-1H-isoquinoline |
| SMILES | CN1CCC(O)(c2ccc(Cl)cc2)CC1.CN1CCc2ccccc2C1 |
| InChI | InChI=1S/C12H16ClNO.C10H13N/c1-14-8-6-12(15,7-9-14)10-2-4-11(13)5-3-10;1-11-7-6-9-4-2-3-5-10(9)8-11/h2-5,15H,6-9H2,1H3;2-5H,6-8H2,1H3 |
| InChIKey | HOOMPVDGLAXGFK-UHFFFAOYSA-N |
| XLogP | 3.93 |
| TPSA | 26.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 372.94 |
| LogP ≤ 5 | 3.93 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158541469 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.